SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-018253
Filing Date
2022-05-05
Accepted
2022-05-05 16:13:57
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atra-10q_20220331.htm   iXBRL 10-Q 2439527
2 EX-10.1 atra-ex101_46.htm EX-10.1 662669
3 EX-31.1 atra-ex311_7.htm EX-31.1 16107
4 EX-31.2 atra-ex312_6.htm EX-31.2 16139
5 EX-32.1 atra-ex321_9.htm EX-32.1 8029
6 GRAPHIC g0stvaspaqn2000003.jpg GRAPHIC 9156
7 GRAPHIC g0stvaspaqn2000002.jpg GRAPHIC 21112
8 GRAPHIC g0stvaspaqn2000001.jpg GRAPHIC 3758
  Complete submission text file 0001564590-22-018253.txt   8360770

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA atra-20220331.xsd EX-101.SCH 53090
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atra-20220331_cal.xml EX-101.CAL 53697
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atra-20220331_def.xml EX-101.DEF 138426
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20220331_lab.xml EX-101.LAB 394235
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20220331_pre.xml EX-101.PRE 275677
55 EXTRACTED XBRL INSTANCE DOCUMENT atra-10q_20220331_htm.xml XML 1265409
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 22896409
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences